There was a significant trend for PDE5i/SGCS/ERA monotherapy and PCY-containing regimens among patients prescribed PAH therapy by cardiologists and pulmonologists.
← all excerpts
Real-world use of initial combination treatment in the management of pulmonary arterial hypertension.
1
—
—